What is pneumonia?

Pneumonia is an infection of the lower respiratory tract that can be caused by bacteria, viruses, and fungi. Viral pneumonia occurs when a respiratory virus like influenza or SARS-CoV-2 spreads infection into the lungs. Bacterial pneumonia occurs when certain bacteriae—such as organisms that typically colonize in the nose and throat, or atypical bacteria—infect the lungs. Fungi are not contagious and do not usually cause infection in healthy people, but if a patient’s immune system is already compromised, fungal pneumonia can occur.

Pneumonia symptoms and signs include cough, fever, shortness of breath, fatigue, and chest pain. People who are high-risk or who are experiencing severe symptoms, like difficulty breathing or a persistent high fever, should be evaluated by a doctor immediately.1

 

What is severe Community-Acquired Pneumonia (sCAP) ?

Severe Community-Acquired Pneumonia (sCAP) is one of the most common causes of acute respiratory distress syndrome.

sCAP is the accepted terminology used to describe ICU-admitted patients with CAP as they might require organ support. It is reported in ∼3% of patients hospitalised with pneumococcal CAP. Mortality due to sCAP remains unacceptably high.2

 

ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia3

BENEFITS OF PNEUMONIA MULTIPLEX PCR TESTING FOR SCAP PATIENTS

REDUCTION OF ANTIBIOTIC TREATMENT DURATION USING SERUM PCT

STRATIFICATION FOR SEVERITY AND ANTIBIOTIC & ADJUVANT TREATMENT

WATCH THE REPLAY NOW

November 13ᵗʰ - 2 PM (CET)

SPEAKER
Prof. Ignacio MARTIN-LOECHES*

CHAIRMAN
Prof. Julien TEXTORIS

 

 

*Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organisation (MICRO), St James’s Hospital, Dublin, Ireland

 

Discover bioMérieux solutions :

BIOFIRE® FILMARRAY® Pneumonia and Pneumonia plus Panels

1 test. Up to 34 Targets. ~1 Hour.

Targets a comprehensive menu of bacteria and viruses that cause Pneumonia and other lower respiratory tract infections, as well as 7 genetic markers of antibiotic resistance.

 

BIOFIRE® Respiratory 2.1 and 2.1 plus Panels

1 test. Up to 23 targets. ~45mins.

Targets a comprehensive menu of up to 23 viral and bacterial pathogens, including Influenza, RSV, and SARS CoV-2.

 

VIDAS® B•R•A•H•M•S PCT™

Aids in the risk assessment for progression to severe sepsis and septic shock, in only 20 minutes.

Want to know more about the benefits of testing our BIOFIRE® Respiratory Solutions and VIDAS® B.R.A.H.M.S PCT™ together?

 

By submitting this form, you agree to the processing of your personal data in accordance with our Privacy Statement.

References

https://www.who.int/news-room/fact-sheets/detail/pneumonia
2,3. Martin-Loeches, I., A. Torres, B. Nagavci, S. Aliberti, M. Antonelli, M. Bassetti, L. Bos, J. Chalmers, L. Derde, J. de Waele, J. Garnacho-Montero, M. Kollef, C. Luna, R. Menendez, M. Niederman, D. Ponomarev, M. Restrepo, D. Rigau, M. Schultz, E. Weiss, T. Welte and R. Wunderink (2023). "ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia." Intensive Care Med: 1-18.